US5420113AExpiredUtility
[Leu13]motilin, DNAs coding for same and methods for producing same
Est. expirySep 12, 2006(expired)· nominal 20-yr term from priority
C07K 2319/75C07K 14/61A61K 38/00C07K 14/63C07K 2319/00C12N 15/70C07K 5/1019
35
PatentIndex Score
1
Cited by
57
References
4
Claims
Abstract
A novel motilin analog peptide containing leucine instead of the usual 13th amino acid methionine, as in the naturally occurring motilin, is produced by gene recombination techniques in which several or identical genes, each coding for the novel peptide, are joined in series into a vector. The resultant recombinant DNA is introduced into Escherichia coli and the resultant transformant is cultivated. The resulting polymeric peptide can be cleaved to give the desired peptide.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A peptide having the amino acid sequence: ##STR9##
2. A peptide having the amino acid sequence: ______________________________________
1 2 3 4 5 6 7 8 9 10
Phe Val Pro Ile Phe Thr Tyr Gly Glu Leu
______________________________________
11 12 13 14 15 16 17 18 19 20
Gln Arg Leu Gln Glu Lys Glu Arg Asn Lys
______________________________________
21 22
Gly Gln Arg Ile Phe Hse
______________________________________
3. A polymeric peptide having the amino acid sequence: ______________________________________
[Phe Val Pro Ile Phe Thr Tyr Gly Glu Leu Gln Arg Leu Gln
Glu Lys Glu Arg Asn Lys Gly Gln Arg Ile Phe Met].sub.n
______________________________________
wherein n has a value of 2 to 32.
4. A pharmaceutical composition containing a therapeutically effective amount of the peptide of claim 1 together with a pharmaceutically acceptable carrier or diluent.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.